Lactobacillus reuteri V3401 Reduces Inflammatory Biomarkers and Modifies the Gastrointestinal Microbiome in Adults with Metabolic Syndrome: The PROSIR Study.
Carmen Tenorio-JiménezMaría José Martínez-RamírezIsabel Del Castillo-CodesCarmen Arraiza-IrigoyenMercedes Tercero-LozanoJosé CamachoNatalia ChuecaFederico GarcíaJosune OlzaJulio Plaza-DíazLuis FontanaMónica OlivaresÁngel GilCarolina G LlorentePublished in: Nutrients (2019)
Consumption of L. reuteri V3401 improved selected inflammatory parameters and modified the gastrointestinal microbiome. Further studies are needed to ascertain additional beneficial effects of other probiotic strains in MetS as well as the mechanisms by which such effects are exerted.